Linked Data API

Show Search Form

Search Results

1664761
registered interest false more like this
date less than 2023-10-16more like thismore than 2023-10-16
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading NHS: Drugs more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government, further to the proposed update to the 2023 Statutory Scheme to control the cost of branded health services medicines, what policy options were included in the Department of Health and Social Care's long list as alternatives to the options that were included in the final consultation. more like this
tabling member printed
Lord Warner remove filter
uin HL10591 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-10-24more like thismore than 2023-10-24
answer text <p>The statutory scheme consultation sets out the options under consideration. We are in the process of analysing the responses provided, including consideration of any alternative options proposed, and will update on our preferred policy approach later this year. A copy of the impact assessment is attached.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2023-10-24T12:17:36.227Zmore like thismore than 2023-10-24T12:17:36.227Z
answering member
4948
label Biography information for Lord Markham more like this
attachment
1
file name Statutory Scheme Impact Assessment.pdf more like this
title Statutory Scheme Impact Assessment more like this
tabling member
1732
label Biography information for Lord Warner more like this